TheStreet lowered shares of Care.com (NYSE:CRCM) from a b- rating to a c+ rating in a research report sent to investors on Wednesday.

Other research analysts also recently issued reports about the company. Zacks Investment Research downgraded Care.com from a buy rating to a hold rating in a research note on Thursday, October 19th. BidaskClub downgraded Care.com from a buy rating to a hold rating in a research note on Wednesday, October 18th. Finally, Roth Capital upgraded Care.com from a neutral rating to a buy rating and lifted their target price for the stock from $14.00 to $18.00 in a research note on Thursday, November 2nd. Two research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The stock has an average rating of Buy and an average target price of $17.67.

Care.com (NYSE CRCM) opened at $16.94 on Wednesday. Care.com has a one year low of $9.42 and a one year high of $20.88. The company has a market capitalization of $510.82, a P/E ratio of 211.75, a PEG ratio of 2.50 and a beta of 1.01.

In related news, CTO David Krupinski sold 10,000 shares of the business’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $18.65, for a total value of $186,500.00. Following the completion of the sale, the chief technology officer now directly owns 180,678 shares in the company, valued at approximately $3,369,644.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Sheila Lirio Marcelo sold 13,000 shares of the business’s stock in a transaction on Monday, November 20th. The shares were sold at an average price of $18.96, for a total value of $246,480.00. The disclosure for this sale can be found here. Insiders sold a total of 187,874 shares of company stock valued at $3,441,456 over the last 90 days. 24.70% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Janus Henderson Group PLC bought a new stake in Care.com in the 2nd quarter valued at $7,371,000. JPMorgan Chase & Co. bought a new stake in shares of Care.com during the 3rd quarter valued at $1,457,000. Foundry Partners LLC bought a new stake in shares of Care.com during the 3rd quarter valued at $2,700,000. Los Angeles Capital Management & Equity Research Inc. bought a new stake in shares of Care.com during the 3rd quarter valued at $530,000. Finally, Hamilton Lane Advisors LLC bought a new stake in shares of Care.com during the 4th quarter valued at $1,217,000. Institutional investors and hedge funds own 75.08% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Care.com (CRCM) Rating Lowered to C+ at TheStreet” was originally published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece on another website, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this piece can be read at https://theolympiareport.com/2018/02/11/care-com-crcm-rating-lowered-to-c-at-thestreet.html.

Care.com Company Profile

Care.com, Inc is an online marketplace for finding and managing family care. As of December 31, 2016, the Company had 22.8 million members, including 12.9 million families and 9.9 million caregivers, spanning 19 countries. Its consumer matching solutions allow families to search for, qualify, vet, connect with and select caregivers.

Receive News & Ratings for Care.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Care.com and related companies with MarketBeat.com's FREE daily email newsletter.